Boston Scientific Corp (NYSE:BSX)
| 34.69 Delayed Data As of Jul 10 |  +0.19 / +0.55%Today’s Change | 24.10 Today|||52-Week Range 46.62 | -23.29% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Fitzgerald Joseph M |  Sale | 12/13/2019 | 107,692 | $45.00 | $4.8M | -23.09% |
Mahoney Michael F Chairman, President & Chief Executive Officer | Sale | 2/14/2020 | 67,142 | $42.31 | $2.8M | -18.03% |
Mahoney Michael F Chairman, President & Chief Executive Officer | Sale | 1/01/2020 | 36,548 | $45.22 | $1.7M | -23.49% |
Nanavaty Maulik K SVP & President-Neuromodulation | Sale | 8/29/2019 | 34,035 | $42.64 | $1.5M | -19.05% |
Carruthers Wendy Senior Vice President-Human Resources | Sale | 12/13/2019 | 24,220 | $45.03 | $1.1M | -23.09% |
Mirviss Jeffrey B President & Senior Vice President | Sale | 1/17/2020 | 23,077 | $44.00 | $1.0M | -21.68% |
Thepaut Eric Francis Yves | Sale | 11/26/2019 | 22,487 | $42.70 | $960.2K | -19.03% |
Nanavaty Maulik K SVP & President-Neuromodulation | Sale | 11/27/2019 | 20,552 | $43.27 | $889.3K | -19.74% |
Fitzgerald Joseph M |  Buy | 12/13/2019 | 107,692 | $7.41 | $798.0K | -23.09% |
Brennan Daniel J /boston/ Chief Financial Officer & Executive Vice President | Sale | 2/14/2020 | 16,781 | $42.31 | $710.0K | -18.03% |
Page of 29